CG
HZNP

Carmignac Gestion’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Carmignac Gestion’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-68,347
Closed -$7.91M – 169
2023
Q3 		$7.91M Buy
68,347
+31,022
+83% +$3.33M 0.15% 57
2023
Q2 		$3.84M Buy
+37,325
New +$3.94M 0.07% 77

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Carmignac Gestion's HZNP Position: Q4 2023 in Review

Carmignac Gestion sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 68,347 shares — an estimated $7.91M sold.

Carmignac Gestion first reported a position in HZNP in Q2 2023 and held it in 2 quarters. The position peaked at $7.91M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Carmignac Gestion reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Carmignac Gestion sold 68,347 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $7.91M.
  • Carmignac Gestion first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2023 and held it in 2 quarters.
  • Carmignac Gestion's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.91M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Carmignac Gestion's 13F filing for Q4 2023, filed 13 Feb 2024.